Immunization Lab Equipment

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Perkins Elmer. Perkins Elmer offers the Chemagic 360 would be used for on going studies it would replace and old Chemagic MSM1. Vetted and established DNA extraction protocols on these instruments include 1)DNA extraction from formalin-fixed paraffin embedded tissues, 2) cervical epithelial cells in Digene Speciman Transport Medium, 3) cervical epithelial cells in BD SurePath and 4) keratiznized epidermal skin cells in Digene Specimen Transport Medium. A newly acquired Chemagic 360 would be able to use the same regents, supplies and programs as the existing MSM1 does. Therefore the procedurs from the existing MSM1 and 360 can be transferred directly to a new 360 without the time and cost expense of protocol redevelopment on a different instrument platform. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at tgw4@cdc.gov by COB 10, September 2018

.